Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
IBIS is a prospective, observational study, which aims to assess the cost of CDI per day, hospitalization and year including description of incremental costs in hospitalized patients, and recurrent episodes, in German hospitals. Exposure to CDI drugs will not be influenced and remains at the discretion of the treating physician. In addition to treatment, Health-related quality of life (HRQL) will be analyzed using standardized questionnaires.
Epistemonikos ID: 7d0d98e53a00335b487252eb40f3340a15058881
First added on: May 20, 2024